Lupin Shells Out $880M For NJ-Based Pharma Co.
Lupin Ltd. said Thursday it has reached an agreement to acquire New Jersey-based Gavis Pharmaceuticals LLC and its manufacturing affiliate, Novel Laboratories Inc., in an $880 million transaction that will boost the...To view the full article, register now.
Already a subscriber? Click here to view full article